Canada markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
30.35-1.00 (-3.19%)
At close: 4:00PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
Total Revenue
92,292
78,893
90,891
78,626
93,468
Cost of Revenue
54,237
46,327
56,315
53,530
58,809
Gross Profit
38,055
32,566
34,576
25,096
34,659
Operating Expenses
Research Development
69,450
64,152
59,630
62,594
65,324
Selling General and Administrative
73,991
72,799
75,491
63,489
59,119
Total Operating Expenses
143,441
136,951
135,121
126,083
124,443
Operating Income or Loss
-105,386
-104,385
-100,545
-100,987
-89,784
Interest Expense
1,789
267
2,611
2,423
2,921
Total Other Income/Expenses Net
47,881
134,055
19,022
848
516
Income Before Tax
-59,294
29,403
-84,134
-102,562
-92,189
Income from Continuing Operations
-59,294
29,403
-84,134
-102,562
-92,189
Net Income
-59,294
29,403
-84,134
-102,562
-92,189
Net Income available to common shareholders
-59,294
29,403
-84,134
-102,562
-92,189
Basic EPS
-
0.18
-0.55
-0.76
-0.87
Diluted EPS
-
0.17
-0.55
-0.76
-0.87
Basic Average Shares
-
165,187
152,527
135,094
105,682
Diluted Average Shares
-
174,970
152,527
135,094
105,682
EBITDA
-
38,974
-71,575
-92,924
-80,826